Back to AL Alphabet Inc.
TSHA22 quarters
Position history for ALAlphabet Inc.'s holdings in TAYSHA GENE THERAPIES INC
No. Alphabet exited its TSHA (Taysha Gene Therapies) position in Q4 2025. Its Q3 2025 13F listed 640,882 shares worth $2.1M. Alphabet first reported TSHA in Q3 2020 and held it in 21 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$14.4M
Total Shares Change
-640,882
Quarter-by-Quarter History
Other major holders of TSHA: Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, FMR LLC, BlackRock, Inc.